A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed

被引：0
|
作者：
Halabi, Susan
Lin, Chen-Yen
Small, Eric Jay
Armstrong, Andrew J.
Kaplan, Ellen B.
Petrylak, Daniel Peter
Sternberg, Cora N.
Shen, Liji
Oudard, Stephane
De Bono, Johann Sebastian
Sartor, A. Oliver
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Durham, NC USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[4] Duke Univ, Div Med Oncol & Urol, Duke Canc Inst, Durham, NC USA
[5] Duke Univ, Div Med Oncol & Urol, Duke Prostate Ctr, Durham, NC USA
[6] Yale Univ, Smilow Canc Hosp, New Haven, CT USA
[7] San Camillo & Forlanini Hosp, Rome, Italy
[8] Sanofi, Malvern, PA USA
[9] Hop Europeen Georges Pompidou, Paris, France
[10] Inst Canc Res, London SW3 6JB, England
[11] Tulane Canc Ctr, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic value of various summary measures of prostate-specific antigen (PSA) kinetics for overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) who failed first-line chemotherapy (TROPIC trial).
    Legrand, Catherine
    Oudard, Stephane
    Sartor, A. Oliver
    De Bono, Johann Sebastian
    Shen, Liji
    Machiels, Jean-Pascal H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth
    de Wit, Ronald
    Tannock, Ian
    Eisenberger, Mario
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 203 - 211
  • [23] The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer
    Park, Jong Chul
    Pratz, Caroline F.
    Tesfaye, Anteneh
    Brodsky, Robert A.
    Antonarakis, Emmanuel S.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 32 - 38
  • [24] First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices
    Turpin, Anthony
    Pasquier, David
    Massard, Christophe
    Berdah, Jean-Francois
    Culine, Stephane
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (06) : 552 - 558
  • [25] The evolution and current paradigm of chemotherapy for metastatic castrate-resistant prostate cancer
    Payne, Heather A.
    Aggarwal, Ajay
    Woolf, David K.
    JOURNAL OF CLINICAL UROLOGY, 2011, 4 (01) : S2 - S8
  • [26] Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer
    Tucker, Matthew D.
    Zhu, Jason
    Marin, Daniele
    Gupta, Rajan T.
    Gupta, Santosh
    Berry, William R.
    Ramalingam, Sundhar
    Zhang, Tian
    Harrison, Michael
    Wu, Yuan
    Healy, Patrick
    Lisi, Stacey
    George, Daniel J.
    Armstrong, Andrew J.
    CANCER MEDICINE, 2019, 8 (10): : 4644 - 4655
  • [27] Maximizing survival in metastatic castrate-resistant prostate cancer: a clinical viewpoint
    Birtle, Alison
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (01) : 89 - 99
  • [28] Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival
    Francini, Edoardo
    Fiaschi, Anna I.
    Petrioli, Roberto
    Bianco, Vincenzo
    Laera, Letizia
    Francini, Filippo
    Roviello, Giandomenico
    ANTI-CANCER DRUGS, 2015, 26 (08) : 910 - 911
  • [29] Use of speed and extent of PSA response during the first three cycles of docetaxel chemotherapy in metastatic castrate-resistant prostate cancer to predict overall survival
    Goody, R. B.
    Mitchell, D. M.
    McAleese, J.
    O'Sullivan, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [30] Association of Overall Survival with Glycolytic Activity of Castrate-Resistant Prostate Cancer Metastases
    Jadvar, Hossein
    Groshen, Susan G.
    Quinn, David I.
    RADIOLOGY, 2015, 274 (02) : 624 - 625
12345